E-mail: brez@uhkt.cz
Odborné práce publikované na Linkos.cz
Přehled odborných textů publikovaných autorem na portálu Linkos.cz. Jsou zde uvedeny knihy a brožury, články v Klinické onkologii, tuzemská abstrakta z databáze abstrakt a další texty. Rejstřík není v žádném případě úplným autorským rejstříkem, protože jsou zde uvedeny pouze texty zveřejněné na portálu Linkos.cz.
Publikovaná abstrakta
- A Lack of Correlation between EVI1 Expression, MDS Subtype and Karyotype Abnormalities Suggests Multiple Pathways Involved in EVI1 Impact on Hematopoietic Cells in MDS Patients.
- Acute Leukaemias with TEL/ABL Fusion: a Subgroup with Poor Prognosis and Prenatal Origin
- Amplifikácia MLL génu u pacienta s akútnou myeloidnou leukémiou (AML)
- ATYPICAL DELETED SEGMENTS IN THREE PATIENTS WITH MYELOID MALIGNANCIES AND DELETION 5Q
- CLONAL EVOLUTION STUDIED BY I-FISH IN B-CLL
- Clonal Heterogeneity in Patients with Myelodysplastic Syndromes (MDS) and Complex Karyotypes
- COMPLEX CHROMOSOMAL ABERRATIONS IN BONE MARROW CELLS OF 86 PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
- COMPLEX CHROMOSOMAL REARRANGEMENTS IN ADULT PATIENTS WITH AML ARE INDEPENDENT PROGNOSTIC FACTOR
- DASATINIB EFFICACY AND TOLERANCE IN THE TREATMENT OF CHRONIC MYELOID LEUKEMIA (CML) PATIENTS RESISTANT/INTOLERANT TO IMATINIB IN THE CONTEXT OF REAL CLINICAL PRACTICE MANAGEMENT
- DASATINIB EVEN AT LOWER DOSES IS AN EFFECTIVE FOR CHRONIC MYELOID LEUKAEMIA TREATMENT IN PATIENTS RESISTANT OR INTOLERANT TO IMATINIB
- DETECTION OF STRUCTURAL ABERRATIONS OF CHROMOSOME 7 IN MYELOID MALIGNANCIES USING COMBINATION OF MOLECULAR CYTOGENETIC TECHNIQUES
- EFFECT OF LENALIDOMIDE TREATMENT ON THE EXPRESSION OF FLI1, EKLF, TP53, HDM2, PU. 1 AND IL-6 GENES IN 5Q- SYNDROME
- ESTIMATION OF THE CURRENT SURVIVAL MEASURES IN CHRONIC MYELOID LEUKEMIA: METHODOLOGY AND NEW SOFTWARE TOOLS
- Frequency and Prognostic Impact of Complex Chromosomal Aberrations in Patients with Primary Myelodysplastic Syndromes and Del(5q)
- HAS SIMULTANEOUS PREGNANCY NEGATIVELY INFLUENCED PROGRESSION AND TREATMENT RESPONSE IN CML?
- High Cereblon Expression In Lower Risk Myelodysplastic Syndromes With 5q Deletion Is Associated With The Efficacy Of Lenalidomide
- HIGH LEVELS OF CEREBLON MESSENGER RNA ARE THE CHARACTERISTIC FEATURE OF LOWER RISK MYELODYSPLASTIC SYNDROMES WITH 5Q DELETION AND ARE CONNECTED WITH THE EFFICACY OF LENALIDOMIDE
- CHROMOSOME 3 ABERRATIONS IN MYELOID MALIGNANCIES REVEALED BY MOLECULAR CYTOGENETIC TECHNIQUES AND THEIR PROGNOSTIC SIGNIFICANCE
- CHROMOTHRIPSIS IN BONE MARROW CELLS OF ADULT PATIENTS WITH NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROMES (MDS) WITH COMPLEX KARYOTYPES
- IDH1 (BUT NOT IDH2) MUTATIONS CAUSE INFERIOR OUTCOME IN PATIENTS WITH AML WITH AN INTERMEDIATE-RISK CYTOGENETICS
- IMATINIB IN THE TREATMENT OF ELDERLY PATIENTS WITH PH CML IN THE LATE CHRONIC PHASE
- Incidence a prognostický význam chromozomových změn u myelodysplastického syndromu
- Komplexní změny karyotypu u pacientů s mnohočetným myelomem (MM)
- Molecular Cytogenetic Studies of Complex Karyotypes in Myelodysplastic Syndromes (MDS): Conventional Cytogenetics, FISH and Multiplex FISH (mFISH/mBAND)
- Molekulárně cytogenetická analýza buněk mozkových tumorů
- Molekulárně cytogenetická analýza buněk mozkových tumorů
- MUTATIONS OF ASXL1 GENE IN PATIENTS WITH AML WITH AN INTERMEDIATE-RISK CYTOGENETIC PROFILE
- Neinvazivní diagnostika karcinomu močového měchýře metodou I-FISH
- PROGNOSTIC SIGNIFICANCE OF ADDITIONAL CHROMOSOMAL ABERRATIONS IN CHILDREN WITH ETV6-AML1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
- PROGNOSTIC SIGNIFICANCE OF COMPLEX CHROMOSOMAL REARRANGEMENTS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
- PROGNOSTIC SIGNIFICANCE OF TELOMERE LENGTH, MOLECULAR CYTOGENETIC FINDINGS AND IMMUNOPHENOTYPIC FEATURES IN PATIENTS WITH B-CHRONIC LYMPHOCYTIC LEUKEMIA
- Putative Monosomy 5 In Myelodysplastic Syndromes (MDS) Is Probably Resulting From Chromothripsis
- Sledování klonálního vývoje u B-CLL metodou I-FISH
- SUCCESSFUL MANAGEMENT OF CML DURING PREGNANCY AND IN POST-PARTUM PERIOD
- TELOMERE LENGTH EVALUATION IN PATIENTS WITH UNTREATED B-CHRONIC LYMPHOCYTIC LEUKEMIA - CORRELATION WITH OTHER MOLECULAR, CYTOGENETIC AND IMMUNOPHENOTYPIC FEATURES
- The Prognostic Significance of TP53
- THE ROLE OF TP53 MUTATIONS IN LOW-RISK MDS PATIENTS
- The Significance of Megakaryocytic Transcription Factor Fli1 and Erythroid Transcription Factor EKLF in the Ribosomopathies: 5q Minus Syndrome and Diamond-Blackfan Anemia. the Role of Fli1 in p53 Regulation and in 5q Minus Syndrome Megakaryopoiesis
- THE UNUSUAL MLL REARRANGEMENT IN ACUTE MYELOID LEUKEMIA
- TRUE MONOSOMY OF CHROMOSOME 5 IS PRESUMABLY NOT AN ISOLATED CYTOGENETIC ENTITY IN MDS
